Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 13Lymphoid 11Tumor-Agnostic 3Thoracic 3Breast 3Plasma cell 2Genitourinary 2Gastrointestinal 2Myeloid 1Gynecologic 1

Conditions

Prostatic Neoplasms 1310Carcinoma, Renal Cell 661Urinary Bladder Neoplasms 405Carcinoma, Non-Small-Cell Lung 334Neoplasms 301Carcinoma, Transitional Cell 264Breast Neoplasms 252Ovarian Neoplasms 248Melanoma 235Colorectal Neoplasms 228Neoplasm Metastasis 214Kidney Neoplasms 200Pancreatic Neoplasms 169Stomach Neoplasms 162Squamous Cell Carcinoma of Head and Neck 143Lung Neoplasms 140Uterine Cervical Neoplasms 123Non-Muscle Invasive Bladder Neoplasms 118Triple Negative Breast Neoplasms 112Head and Neck Neoplasms 111Endometrial Neoplasms 109Esophageal Neoplasms 107Carcinoma, Hepatocellular 98Small Cell Lung Carcinoma 80Sarcoma 75Colonic Neoplasms 55Urologic Neoplasms 53Prostatic Neoplasms, Castration-Resistant 47Liver Neoplasms 47Cholangiocarcinoma 43

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Neoplasm, Residual × Genitourinary × Clear all
NCT05219734 2024-03-12

MARIA

Invitae Corporation

Active not recruiting
400 enrolled
GastrointestinalGenitourinaryThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Neoplasms, Colorectal Neoplasms, Neoplasm, Residual

NCT03441464 2022-02-25

Feasibility of the LUM Imaging System for Detection of Prostate Cancer

Lumicell, Inc.

Phase 1/2 Terminated
9 enrolled
Genitourinary

Prostatic Neoplasms, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡